Anzeige
Meldung des Tages: Der Vorteil des Meeresbodens: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

AbbVie News

Aktie
WKN:  A1J84E ISIN:  US00287Y1091 US-Symbol:  ABBV Branche:  Pharmazeutika Land:  USA
177,10 €
+0,1 €
+0,06%
09:30:26 Uhr
Depot/Watchlist
Marktkapitalisierung *
345,80 Mrd. €
Streubesitz
24,69%
KGV
21,69
Dividende
5,85 EUR
Dividendenrendite
3,05%
Nachhaltigkeits-Score
54 %
Index-Zuordnung
S&P 500
Weiter aufwärts? Long handeln - Jetzt mit Hebel 5,08: VM6TD3
Werbung

AbbVie News

14.04.26 - PR Newswire
Erin Lichy Gets Real About Her Natrelle® Breast Augmentation
Erin Lichy Gets Real About Her Natrelle® Breast Augmentation PR Newswire
12.04.26 - PR Newswire
AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026
AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-​gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026 PR Newswire
08.04.26 - PR Newswire
BOTOX® Cosmetic (onabotulinumtoxinA) Empowers Women Entrepreneurs Through "The Confidence Collective" for Fourth Year
BOTOX® Cosmetic (onabotulinumtoxinA) Empowers Women Entrepreneurs Through "The Confidence Collective" for Fourth Year PR Newswire
07.04.26 - PR Newswire
Allergan Aesthetics Third State-of-the-Art AMI Center Opens in Austin
Allergan Aesthetics Third State-​of-the-Art AMI Center Opens in Austin PR Newswire
04.04.26 wallstreetONLINE Redaktion
Substanz gegen Multi-Krisen: Morningstar adelt JPMorgan-ETF: Warum dieser Dividendenfonds jetzt auffällt
Während der S&P 500 deutlicher fällt, stemmt sich dieser Dividenden-​ETF von JPMorgan gegen den Abwärtssog. Morningstar lobt ihn, und der Fonds-​Manager setzt jetzt auf globale ...
31.03.26 - PR Newswire
/C O R R E C T I O N -- AbbVie/
/C O R R E C T I O N -- AbbVie/ PR Newswire
31.03.26 - PR Newswire
AbbVie to Host First-Quarter 2026 Earnings Conference Call
AbbVie to Host First-​Quarter 2026 Earnings Conference Call PR Newswire
30.03.26 - PR Newswire
Allergan Aesthetics Releases Findings on the Safety and Efficacy of Repeat TrenibotE Treatments and Data on Medical Weight Loss Aesthetics Patient Behaviors at the 2026 American Academy of Dermatology Meeting (AAD)
Allergan Aesthetics Releases Findings on the Safety and Efficacy of Repeat TrenibotE Treatments and Data on Medical Weight Loss Aesthetics Patient Behaviors at the 2026 ...
27.03.26 - Société Générale
Ausblick auf AbbVie – Bounce vom Support
Die AbbVie -Aktie (WKN: A1J84E) war vom im April 2025 bei 164,39 USD verzeichneten Korrekturtief bis auf ein im Oktober bei 244,81 USD markiertes Allzeithoch haussiert. Seither ...
27.03.26 - PR Newswire
AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting
AbbVie to Highlight New Clinical and Real-​World Evidence Advancing Standards of Care in Immune-​Mediated Skin Diseases at the 2026 AAD Annual Meeting PR Newswire
26.03.26 - PR Newswire
Allergan Aesthetics Reinforces Scientific Differentiation and Leadership with 21 Evidence-Based E-Posters at the 2026 Aesthetic & Anti-Aging Medicine World Congress (AMWC)
Allergan Aesthetics Reinforces Scientific Differentiation and Leadership with 21 Evidence-​Based E-Posters at the 2026 Aesthetic & Anti-​Aging Medicine World Congress (AMWC) PR ...
26.03.26 - PR Newswire
Allergan Aesthetics Ushers in a New Age of Hyaluronic Acid (HA) Injectables with JUVÉDERM® at AMWC Monaco
Allergan Aesthetics Ushers in a New Age of Hyaluronic Acid (HA) Injectables with JUVÉDERM® at AMWC Monaco PR Newswire
24.03.26 - PR Newswire
AbbVie Named Official Pharmaceutical Partner of Major League Baseball
AbbVie Named Official Pharmaceutical Partner of Major League Baseball PR Newswire
19.03.26 - PR Newswire
Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions
Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions PR Newswire
13.03.26 - dpa-AFX
ROUNDUP: Botox und Co. - Minimalinvasive Eingriffe immer gefragter
Immer mehr Menschen lassen minimalinvasive Eingriffe beim Schönheitschirurgen durchführen. Zu minimalinvasiven Eingriffen gehören zum Beispiel Behandlungen mit Botox ...
09.03.26 - PR Newswire
AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults
AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-​Acting Amylin Analog, in Adults PR Newswire
04.03.26 - PR Newswire
ALLERGAN AESTHETICS HIGHLIGHTS MEDICAL WEIGHT LOSS (MWL) DATA AND THE CHANGING PROFILE OF PATIENTS
ALLERGAN AESTHETICS HIGHLIGHTS MEDICAL WEIGHT LOSS (MWL) DATA AND THE CHANGING PROFILE OF PATIENTS PR Newswire
03.03.26 - PR Newswire
AbbVie to Present at the Leerink Partners Global Healthcare Conference
AbbVie to Present at the Leerink Partners Global Healthcare Conference PR Newswire
02.03.26 - PR Newswire
AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease
AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease PR Newswire
24.02.26 - PR Newswire
AbbVie to Present at the TD Cowen 46th Annual Health Care Conference
AbbVie to Present at the TD Cowen 46th Annual Health Care Conference PR Newswire

Newssuche

Videos

newspaper
16.04.26 +0,31%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »